Chesterfield, MO, United States of America

Matthew Paul LaConte

USPTO Granted Patents = 5 

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Wildwood, MO (US) (2015)
  • Chesterfield, MO (US) (2014 - 2022)

Company Filing History:


Years Active: 2014-2022

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Matthew Paul LaConte

Introduction: Matthew Paul LaConte, hailing from Chesterfield, MO, is a notable inventor recognized for his significant contributions to the medical field through his innovative surgical devices. With a total of five patents to his name, LaConte's work has greatly influenced modern surgical techniques.

Latest Patents: The latest patents attributed to Matthew Paul LaConte focus on surgical devices equipped with a triggered propulsion system for the insertion of a trocar-cannula assembly. These inventions detail surgical devices that include a trocar and a cannula, which is releasably mounted on the trocar. The propulsion system connected to the trocar allows for axial movement in a forward direction, enhancing the efficiency and effectiveness of surgical procedures.

Career Highlights: Throughout his career, LaConte has worked with reputable companies such as Synergetics, Inc. and Synergetics USA, Inc. His roles at these organizations have been instrumental in the development and refinement of surgical technologies.

Collaborations: Matthew Paul LaConte has collaborated with industry professionals, including Matthew A. Hanlon and James C. Easley. Together, they have pushed the boundaries of innovation in surgical devices, contributing to advancements that benefit healthcare providers and patients alike.

Conclusion: As an inventor, Matthew Paul LaConte continues to make a lasting impact on the field of surgery. His inventive spirit and dedication to improving surgical equipment exemplify the importance of innovation in healthcare, ensuring that his contributions will resonate in the medical community for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…